Avadel

is an Ireland-based pharmaceutical company that researches and develops novel therapeutics for the treatment of excessive daytime sleepiness and cataplexy...
Read more
Avadel CEO: Gregory J. Divis

CEO

Gregory J. Divis

CEO Approval Rating

84/100

Annual Revenue
$248.5M
Employees
154
Funding
$75M

Trending Companies